Soo-Jin Kim
Chief Tech/Sci/R&D Officer at INOZYME PHARMA, INC.
Net worth: 2 M $ as of 2024-04-29
Profile
Soo-Jin Kim is currently the Chief Technical Operations Officer & Senior VP at Inozyme Pharma, Inc. Prior to this, he worked as a Principal Scientist at Bristol Myers Squibb Co., Senior Research & Head-API Development Group at Boehringer Ingelheim Pharmaceuticals, Inc., and Senior Vice President & Head-Bio Plant at Hanmi Pharmaceutical Co., Ltd.
Kim received his undergraduate degree from Cornell University and his graduate and doctorate degrees from the California Institute of Technology.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ILSHIN SPINNING CO., LTD
1.31% | 2023-04-25 | 305,460 ( 1.31% ) | 2 M $ | 2024-04-29 |
Soo-Jin Kim active positions
| Companies | Position | Start |
|---|---|---|
| INOZYME PHARMA, INC. | Chief Tech/Sci/R&D Officer | 2022-03-07 |
Former positions of Soo-Jin Kim
| Companies | Position | End |
|---|---|---|
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Corporate Officer/Principal | - |
| HANMI PHARM. CO., LTD. | Corporate Officer/Principal | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Training of Soo-Jin Kim
| Cornell University | Undergraduate Degree |
| California Institute of Technology | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| HANMI PHARM. CO., LTD. | Health Technology |
| INOZYME PHARMA, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Health Technology |
- Stock Market
- Insiders
- Soo-Jin Kim
